AUPO871997A0 - Dried biologically or therapeutically active preparations - Google Patents

Dried biologically or therapeutically active preparations

Info

Publication number
AUPO871997A0
AUPO871997A0 AUPO8719A AUPO871997A AUPO871997A0 AU PO871997 A0 AUPO871997 A0 AU PO871997A0 AU PO8719 A AUPO8719 A AU PO8719A AU PO871997 A AUPO871997 A AU PO871997A AU PO871997 A0 AUPO871997 A0 AU PO871997A0
Authority
AU
Australia
Prior art keywords
therapeutically active
active preparations
dried biologically
biologically
dried
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPO8719A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CSL Ltd
Original Assignee
CSL Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CSL Ltd filed Critical CSL Ltd
Priority to AUPO8719A priority Critical patent/AUPO871997A0/en
Publication of AUPO871997A0 publication Critical patent/AUPO871997A0/en
Priority to ZA987633A priority patent/ZA987633B/en
Priority to CA002301514A priority patent/CA2301514A1/en
Priority to PCT/AU1998/000682 priority patent/WO1999010011A1/en
Priority to EP98938550A priority patent/EP1009438A1/en
Priority to PL98338856A priority patent/PL338856A1/en
Priority to NZ503034A priority patent/NZ503034A/en
Priority to AU87231/98A priority patent/AU8723198A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AUPO8719A 1997-08-25 1997-08-25 Dried biologically or therapeutically active preparations Abandoned AUPO871997A0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
AUPO8719A AUPO871997A0 (en) 1997-08-25 1997-08-25 Dried biologically or therapeutically active preparations
ZA987633A ZA987633B (en) 1997-08-25 1998-08-24 Dried biologically or therapeutically active preparations
CA002301514A CA2301514A1 (en) 1997-08-25 1998-08-25 Dried biologically or therapeutically active preparations
PCT/AU1998/000682 WO1999010011A1 (en) 1997-08-25 1998-08-25 Dried biologically or therapeutically active preparations
EP98938550A EP1009438A1 (en) 1997-08-25 1998-08-25 Dried biologically or therapeutically active preparations
PL98338856A PL338856A1 (en) 1997-08-25 1998-08-25 Dried biologically or therapeutically active preparations
NZ503034A NZ503034A (en) 1997-08-25 1998-08-25 Dried biologically or therapeutically active Factor VIII preparations
AU87231/98A AU8723198A (en) 1997-08-25 1998-08-25 Dried biologically or therapeutically active preparations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPO8719A AUPO871997A0 (en) 1997-08-25 1997-08-25 Dried biologically or therapeutically active preparations

Publications (1)

Publication Number Publication Date
AUPO871997A0 true AUPO871997A0 (en) 1997-09-18

Family

ID=3803005

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPO8719A Abandoned AUPO871997A0 (en) 1997-08-25 1997-08-25 Dried biologically or therapeutically active preparations

Country Status (7)

Country Link
EP (1) EP1009438A1 (en)
AU (1) AUPO871997A0 (en)
CA (1) CA2301514A1 (en)
NZ (1) NZ503034A (en)
PL (1) PL338856A1 (en)
WO (1) WO1999010011A1 (en)
ZA (1) ZA987633B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001270900A (en) * 2000-03-23 2001-10-02 Nihon Pharmaceutical Co Ltd Method for inactivating virus in fibrinogen
AU2001244584B2 (en) 2000-03-31 2006-01-19 Kirin Pharma Kabushiki Kaisha Powdery preparation for transmucosal administration containing a polymeric form of drug and exhibiting improved storage stability
DE60229961D1 (en) * 2001-08-29 2009-01-02 Chugai Pharmaceutical Co Ltd ANTIBODIES CONTAINING STABILIZED PREPARATIONS
FR2857267B1 (en) * 2003-07-09 2006-03-10 Lab Francais Du Fractionnement STABILIZING AND SOLUBILIZING FORMULATION FOR CRYOPRECIPITABLE PROTEINS.
KR100624013B1 (en) * 2004-06-25 2006-09-19 주식회사 녹십자홀딩스 Pharmaceutical preparation of recombinant factor ? lyophilized without albumin as a stabilizer
AU2008260483A1 (en) * 2007-06-01 2008-12-11 Acologix, Inc. High temperature stable peptide formulation
WO2008155529A1 (en) * 2007-06-16 2008-12-24 Enigma Diagnostics Limited Compositions
MX2011001624A (en) 2008-08-21 2011-03-28 Octapharma Ag Recombinantly produced human factor viii and ix.
EP3212212B1 (en) 2014-10-31 2020-09-23 Monash University Powder formulation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2916711A1 (en) * 1979-04-25 1980-11-06 Behringwerke Ag Blood coagulation factors and process for their manufacture
US4623717A (en) * 1980-03-05 1986-11-18 Miles Laboratories, Inc. Pasteurized therapeutically active protein compositions
JPS5874617A (en) * 1981-10-28 1983-05-06 Green Cross Corp:The Heat-treating method of aqueous solution containing blood coagulation factor 8 derived from human
DE3237512A1 (en) * 1982-10-09 1984-04-12 Behringwerke Ag, 3550 Marburg METHOD FOR PASTEURIZING ANTIHAEMOPHILIC CRYOPRAEZIPITATE (AHK) AND ANTIHAEMOPHILE CRYOPRAECIPITATE PRODUCED THEREOF
US4891319A (en) * 1985-07-09 1990-01-02 Quadrant Bioresources Limited Protection of proteins and the like
JPH06157294A (en) * 1992-11-19 1994-06-03 Tanabe Seiyaku Co Ltd Fine-granular fat preparation
GB9501040D0 (en) * 1995-01-19 1995-03-08 Quadrant Holdings Cambridge Dried composition

Also Published As

Publication number Publication date
CA2301514A1 (en) 1999-03-04
WO1999010011A1 (en) 1999-03-04
ZA987633B (en) 1999-02-25
EP1009438A1 (en) 2000-06-21
NZ503034A (en) 2001-02-23
PL338856A1 (en) 2000-11-20

Similar Documents

Publication Publication Date Title
AU7908098A (en) Biologically active 1,3-bis-aromatic-prop-2-en-1-ones, 1,3-bis-aromatic-propan-1-ones, and 1,3-bis-aromatic-prop-2-yn-1-ones
GB2332147B (en) Therapeutically active compositions
AU6126798A (en) Restricted mobility area
AU8166098A (en) Removal of biologically active agents
AU6086398A (en) Image-directed active range finding system
AU4217197A (en) Biologically active phosphotriester-type compounds
AU2380595A (en) Biologically active composition
AU4944997A (en) Deodorizing preparations
AU2080199A (en) New pharmaceutically active compounds
AUPO871997A0 (en) Dried biologically or therapeutically active preparations
AU8825198A (en) Biologically active glass-based substrate
AU4377397A (en) Novel therapeutically active adenosine derivatives
AU5531798A (en) Pharmacologically active compounds and use
AU8750198A (en) Antibiotic preparations and use of the same
AU2904497A (en) Shelter
AU6156294A (en) Physiologically active peptide
AU7600598A (en) Human metaxin protein
AU1093697A (en) Active bio-compounds
AU5337198A (en) Production of biologically active polypeptides
AU1042899A (en) Castor
AU1179600A (en) Physiologically active peptides
AU2177597A (en) Physiologically active substance ei-2128-1
AU6582694A (en) Biologically active peptides
AU6782298A (en) Fibrocyte-based cellular therapy formulations
AU1513501A (en) Biologically active material